Life sciences companies have faced a turbulent 2025. Here's what Philadelphia's biotech leaders are saying about the state of ...

California biotech company Cellipont has opened a new 76,000 square foot cell therapy headquarters in The Woodlands' booming ...

Preliminary data recently shared for eti-cel (UCART20x22) show an 86% ORR and a 57% CR rate (n=7), underscoring its potential to improve outcomes in r/r NHLPreclinical data demonstrated that combining ...

I traded cloud convenience for total control, and Trilium Next turned out to be one of the most powerful Notion replacements ...

One dose of an experimental drug cover offer lifetime treatment for people with high cholesterol, but its long-term safety is ...

An experimental gene-editing treatment shows promise for permanently lowering levels of cholesterol and triglycerides, ...

CBS News' "60 Minutes" gave its audience a rare opportunity by releasing a full, unedited video and transcript of its ...

(Nasdaq: IONS) today announced positive results from the pivotal Phase 3 CORE and CORE2 studies of olezarsen in people with severe hypertriglyceridemia (sHTG). The studies met the primary endpoint, ...

On this week's episode of Behind the Ballot, Sam McKewon and Ben Doody talk about Nebraska's long-shot hopes to get back into ...

Grimsley and Reidsville each earned No. 1 seeds, while Northern Guilford and Northeast Guilford each received second seeds in ...

Microsoft’s cloud-native, distributed application development tool kit drops .NET from its name and embraces, well, ...